Global, regional and national burden of ischaemic heart disease attributable to high body mass index and low physical activity from 1990 to 2021

Documenti analoghi

• Global burden, trends and inequalities for ischaemic heart disease attributable to high fasting plasma glucose, high low‐density lipoprotein cholesterol and high systolic blood pressure, 1990–2021: An analysis of the Global Burden of Disease Study 2021
  di: Jun‐Qiao An, et al.
  Pubblicazione: (2025)
• Global, regional and national burden of blindness and vision loss attributable to diabetic retinopathy, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021
  di: Yujie Pan, et al.
  Pubblicazione: (2025)
• Projecting the macroeconomic burden of high body mass index related diseases in China: A Bayesian productivity‐adjusted life years approach based on global burden of diseases 2023
  di: Zihao Liu, et al.
  Pubblicazione: (2026)
• Mortality risk following ischaemic and non‐ischaemic heart failure in people with type 2 diabetes: Observational study in England, 2000–2021
  di: Kajal Panchal, et al.
  Pubblicazione: (2025)
• Worldwide burden of metabolic risk‐related cardiovascular disease from 1990 to 2021, with projections to 2050: A systematic analysis for the Global Burden of Disease Study 2021
  di: Xinjiang Dong, et al.
  Pubblicazione: (2025)